Year |
Citation |
Score |
2020 |
Gonzalez-Ericsson PI, Stovgaard ES, Sua LF, Reisenbichler E, Kos Z, Carter JM, Michiels S, Le Quesne J, Nielsen TO, Laenkholm AV, Fox SB, Adam J, Bartlett JM, Rimm DL, Quinn C, ... ... Lien H, et al. The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers into breast cancer clinical trials and daily practice. The Journal of Pathology. PMID 32129476 DOI: 10.1002/Path.5406 |
0.316 |
|
2019 |
Lien HC, Lee YH, Juang YL, Lu YT. Fibrillin-1, a novel TGF-beta-induced factor, is preferentially expressed in metaplastic carcinoma with spindle sarcomatous metaplasia. Pathology. PMID 31010590 DOI: 10.1016/J.Pathol.2019.02.001 |
0.368 |
|
2018 |
Kuo SH, Lo C, Chen YH, Lien HC, Kuo WH, Wang MY, Lee YH, Huang CS. Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma-in-Situ Who Received Breast-Conserving Surgery. Clinical Breast Cancer. PMID 29709458 DOI: 10.1016/J.Clbc.2018.04.002 |
0.421 |
|
2018 |
Lai SF, Chen YH, Liang TH, Hsu CY, Lien HC, Lu YS, Huang CS, Kuo SH. The breast graded prognostic assessment is associated with the survival outcomes in breast cancer patients receiving whole brain re-irradiation. Journal of Neuro-Oncology. PMID 29557535 DOI: 10.1007/S11060-018-2833-5 |
0.409 |
|
2016 |
Hsieh MS, Lien HC, Hua SF, Kuo WH, Lee YH. Clear cell hidradenoma of the breast with MAML2 gene rearrangement. Pathology. PMID 27914681 DOI: 10.1016/J.Pathol.2016.09.068 |
0.353 |
|
2016 |
Fan LC, Jeng YM, Lu YT, Lien HC. SPOCK1 Is a Novel Transforming Growth Factor-β-Induced Myoepithelial Marker That Enhances Invasion and Correlates with Poor Prognosis in Breast Cancer. Plos One. 11: e0162933. PMID 27626636 DOI: 10.1371/Journal.Pone.0162933 |
0.438 |
|
2016 |
Lai SF, Chen YH, Kuo WH, Lien HC, Wang MY, Lu YS, Lo C, Kuo SH, Cheng AL, Huang CS. Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1-2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy. Annals of Surgical Oncology. PMID 27436202 DOI: 10.1245/S10434-016-5435-5 |
0.386 |
|
2016 |
Lien HC, Huang CS, Yang YW, Jeng YM. MED12 exon 2 mutation as a highly sensitive and specific marker in distinguishing phyllodes tumours from other spindle neoplasms of the breast. Apmis : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. PMID 26860948 DOI: 10.1111/Apm.12516 |
0.322 |
|
2015 |
Yang CC, LaBaff A, Wei Y, Nie L, Xia W, Huo L, Yamaguchi H, Hsu YH, Hsu JL, Liu D, Lang J, Du Y, Lien HC, Li LY, Deng R, et al. Phosphorylation of EZH2 at T416 by CDK2 contributes to the malignancy of triple negative breast cancers. American Journal of Translational Research. 7: 1009-20. PMID 26279746 |
0.329 |
|
2015 |
Lien HC, Huang CS, Yang YW, Jeng YM. Mutational analysis of MED12 exon 2 in a spectrum of fibroepithelial tumours of the breast: implications for pathogenesis and histogenesis. Histopathology. PMID 26109290 DOI: 10.1111/His.12764 |
0.304 |
|
2015 |
Lien HC, Chen YL, Juang YL, Jeng YM. Frequent alterations of HER2 through mutation, amplification, or overexpression in pleomorphic lobular carcinoma of the breast. Breast Cancer Research and Treatment. 150: 447-55. PMID 25773929 DOI: 10.1007/S10549-015-3336-0 |
0.358 |
|
2015 |
Kuo SH, Chen Y, Kuo W, Lien H, Wang M, Wang C, Huang C. Prognostic significance of clinicopathologic features in patients with breast ductal carcinoma in situ who received breast-conserving therapy. Journal of Clinical Oncology. 33. DOI: 10.1200/Jco.2015.33.15_Suppl.E11574 |
0.431 |
|
2015 |
Lu Y, Yeh D, Tseng L, Chen S, Lien H, Chang H, Chang Y, Huang S, Lin C, Cheng A, Huang C. Randomized study of tailored neoadjuvant chemotherapy according to the expression of tau, topo II α, and ERCC1 versus standard chemotherapy in HER2-negative breast cancer. Journal of Clinical Oncology. 33: 1025-1025. DOI: 10.1200/Jco.2015.33.15_Suppl.1025 |
0.368 |
|
2014 |
Lin JJ, Huang CS, Yu J, Liao GS, Lien HC, Hung JT, Lin RJ, Chou FP, Yeh KT, Yu AL. Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells. Breast Cancer Research : Bcr. 16: R29. PMID 24670249 DOI: 10.1186/Bcr3631 |
0.328 |
|
2014 |
Lien HC, Lee YH, Jeng YM, Lin CH, Lu YS, Yao YT. Differential expression of hyaluronan synthase 2 in breast carcinoma and its biological significance. Histopathology. 65: 328-39. PMID 24527698 DOI: 10.1111/His.12390 |
0.41 |
|
2013 |
Kuo SH, Yang SY, Lien HC, Lo C, Lin CH, Lu YS, Cheng AL, Chang KJ, Huang CS. CYP19 genetic polymorphism haplotype AASA is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer. Biomed Research International. 2013: 562197. PMID 24324964 DOI: 10.1155/2013/562197 |
0.396 |
|
2013 |
Lien HC, Wang CC, Lin CH, Lu YS, Huang CS, Hsiao LP, Yao YT. Differential expression of ubiquitin carboxy-terminal hydrolase L1 in breast carcinoma and its biological significance. Human Pathology. 44: 1838-48. PMID 23664488 DOI: 10.1016/J.Humpath.2013.02.006 |
0.423 |
|
2013 |
Lien HC, Wang CC, Huang CS, Yang YW, Kuo WH, Yao YT. Ubiquitin carboxy-terminal hydrolase L1 may be involved in the development of mammary phyllodes tumors. Virchows Archiv : An International Journal of Pathology. 462: 155-61. PMID 23291960 DOI: 10.1007/S00428-012-1366-0 |
0.341 |
|
2012 |
Wang CC, Liau JY, Lu YS, Chen JW, Yao YT, Lien HC. Differential expression of moesin in breast cancers and its implication in epithelial-mesenchymal transition. Histopathology. 61: 78-87. PMID 22439598 DOI: 10.1111/J.1365-2559.2012.04204.X |
0.445 |
|
2011 |
Chen IC, Lin CH, Huang CS, Lien HC, Hsu C, Kuo WH, Lu YS, Cheng AL. Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era. Breast Cancer Research and Treatment. 130: 345-51. PMID 21792625 DOI: 10.1007/s10549-011-1686-9 |
0.315 |
|
2011 |
Lu Y, Lin C, Hsu C, Lien H, Yeh P, Yeh L, Cheng A. Abstract 364: Impact of glucocorticoid in patients with locally advanced esophageal cancer treated with concurrent chemoradiotherapy Cancer Research. 71: 364-364. DOI: 10.1158/1538-7445.Am2011-364 |
0.366 |
|
2010 |
Hsiao YH, Lien HC, Hwa HL, Kuo WH, Chang KJ, Hsieh FJ. SPARC (osteonectin) in breast tumors of different histologic types and its role in the outcome of invasive ductal carcinoma. The Breast Journal. 16: 305-8. PMID 20210803 DOI: 10.1111/J.1524-4741.2009.00899.X |
0.452 |
|
2010 |
Lin CH, Lien HC, Hu FC, Lu YS, Kuo SH, Wu LC, You SL, Cheng AL, Chang KJ, Huang CS. Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy. Journal of Zhejiang University. Science. B. 11: 1-9. PMID 20043345 DOI: 10.1631/Jzus.B0900295 |
0.362 |
|
2008 |
Huang CS, Kuo SH, Lien HC, Yang SY, You SL, Shen CY, Lin CH, Lu YS, Chang KJ. The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers. The Oncologist. 13: 751-60. PMID 18614591 DOI: 10.1634/Theoncologist.2007-0246 |
0.375 |
|
2008 |
Kuo SH, Lien HC, You SL, Lu YS, Lin CH, Chen TZ, Huang CS. Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients. Breast (Edinburgh, Scotland). 17: 646-53. PMID 18595699 DOI: 10.1016/J.Breast.2008.05.006 |
0.393 |
|
2008 |
Chen C, Tai H, Lien H, Tang Y, Chen M. Angiosarcoma of the Breast and Other Locations Journal of Poultry Science. 17: 119-126. DOI: 10.7096/Jpsa.200806.0119 |
0.423 |
|
2007 |
Kuo WH, Chang LY, Liu DL, Hwa HL, Lin JJ, Lee PH, Chen CN, Lien HC, Yuan RH, Shun CT, Chang KJ, Hsieh FJ. The interactions between GPR30 and the major biomarkers in infiltrating ductal carcinoma of the breast in an Asian population. Taiwanese Journal of Obstetrics & Gynecology. 46: 135-45. PMID 17638621 DOI: 10.1016/S1028-4559(07)60007-2 |
0.41 |
|
2007 |
Yen RF, Kuo WH, Lien HC, Chen TH, Jan IS, Wu YW, Wang MY, Chang KJ, Huang CS. Radio-guided sentinel lymph node biopsy using periareolar injection technique for patients with early breast cancer. Journal of the Formosan Medical Association = Taiwan Yi Zhi. 106: 44-50. PMID 17282970 DOI: 10.1016/S0929-6646(09)60215-1 |
0.371 |
|
2006 |
Su IC, Lien HC, Chen CM. Primary brain T-cell lymphoma after kidney transplantation: a case report. Surgical Neurology. 66: S60-3. PMID 17071259 DOI: 10.1016/J.Surneu.2006.05.024 |
0.305 |
|
2006 |
Xia WY, Lien HC, Wang SC, Pan Y, Sahin A, Kuo YH, Chang KJ, Zhou X, Wang H, Yu Z, Hortobagyi G, Shi DR, Hung MC. Expression of PEA3 and lack of correlation between PEA3 and HER-2/neu expression in breast cancer. Breast Cancer Research and Treatment. 98: 295-301. PMID 16752078 DOI: 10.1007/S10549-006-9162-7 |
0.323 |
|
2005 |
Su MC, Lien HC, Jeng YM. Absence of epidermal growth factor receptor exon 18-21 mutation in hepatocellular carcinoma. Cancer Letters. 224: 117-21. PMID 15911107 DOI: 10.1016/J.Canlet.2004.10.010 |
0.311 |
|
2004 |
Lien HC, Lin CW, Mao TL, Kuo SH, Hsiao CH, Huang CS. p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components. The Journal of Pathology. 204: 131-9. PMID 15376261 DOI: 10.1002/Path.1624 |
0.336 |
|
2001 |
Sheu BC, Lin RH, Lien HC, Ho HN, Hsu SM, Huang SC. Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer. Journal of Immunology (Baltimore, Md. : 1950). 167: 2972-8. PMID 11509647 DOI: 10.4049/Jimmunol.167.5.2972 |
0.308 |
|
2000 |
Chao CK, Sheen TS, Lien HC, Hsu MM. Metastatic carcinoma to the jugular foramen. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 122: 922-3. PMID 10828811 DOI: 10.1067/Mhn.2000.104522 |
0.306 |
|
1999 |
Lien HC, Tsai TF, Lee YY, Hsiao CH. Merkel cell carcinoma and chronic arsenicism. Journal of the American Academy of Dermatology. 41: 641-3. PMID 10495389 DOI: 10.1016/S0190-9622(99)80067-X |
0.317 |
|
Show low-probability matches. |